Sam North
Education
Royal Australian Navy - Electronic and Communications Advanced Diploma (TAFE).
Written For
Releaf, Fast Buds, MSNL, Paradise Seeds, Cookies Seeds, Premium Cultivars
With a background in cannabis journalism - writing for Fast Buds, Paradise Seeds, Cookies Seeds Co., MSNL, and now Releaf, Sam is an experienced cannabis expert who understands how to communicate complex ideas clearly. Collaborating with clients throughout the global cannabis industry, he has cemented himself as a leading voice within both the recreational and medicinal sectors. Whether it’s researching, writing, editing, or consulting, Sam has a commitment to accuracy and quality that clients and audiences connect to. Based between Asia, Australia, and Europe, Sam is passionate about educating and enlightening people on all aspects of cannabis. By translating scientific data into easily understandable language, he strives to bridge the gap between the medical and recreational cannabis communities. Sam believes that with the proper education, correct understanding, and honest information, everyone can benefit from the natural healing power of cannabis.
Releaf articles
Say hello to the new Releaf Starter Kits: PAX or Storz & Bickel
Available right now, Releaf’s new Starter Kits give patients the choice between the compact PAX Mini and the medical-grade Storz & Bickel Venty. Each kit includes carefully selected accessories and CBD products designed to support precise, effective administration of prescribed medical cannabis. Available exclusively through the Releaf Shop for anyone with a Releaf login.
Inside the clinic: UK medical cannabis specialist doctors discuss CBG
CBG is attracting attention as one of the most versatile minor cannabinoids in medical cannabis. This blog brings together reflections from Releaf’s UK medical cannabis specialists on what early research and clinical experience suggest about its potential in patient care.
UK medical cannabis patient survey 2025: Seven years since legalisation
To mark the seventh anniversary of medical cannabis legalisation in the UK, Releaf conducted a nationwide study involving 1,669 patients - the largest survey of prescribed medical cannabis patients ever undertaken in the country.